Rare diseases
Investigational molecules
Locations
Leopold-Ungar-Platz 2, Döbling, 1190 Vienna, Austria
Research activity includes essential thrombocythaemia, with a focus on treatment options for patients who are intolerant of, refractory to, or unsuitable for other cytoreductive therapies.
The clinical interest in this area centres on disease control in a chronic myeloproliferative neoplasm setting.
Aop Orphan Pharmaceuticals GmbH runs clinical trials in conditions such as Pulmonary arterial hypertension, Acute myeloid leukaemia refractory, Acute myeloid leukaemia recurrent, Myelodysplastic syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainAustriaAustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
